Home/Filamon/Stephen Menzies
SM

Stephen Menzies

Non‑Executive Director

Filamon

Filamon Pipeline

DrugIndicationPhase
KESONOTIDE™Broad chronic inflammatory diseasesPreclinical
BETA‑TT8Cancer, cardiovascular disease, neuroinflammatory eye conditionsPreclinical